Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2018-04-12 | George Poste, DVM, Ph.D., FRS, has been a director since August 2004. Since February 2009, Dr. Poste has been the Chief Scientist at Complex Adaptive Systems Initiative and Regents' Professor and Del E. Webb Professor of Health Innovation at Arizona State University. ... Dr. Poste holds a D.V.M. in veterinary medicine and a Ph.D. in Virology from the University of Bristol, England. |
| 2019-04-11 | Dr. Poste holds a DVM in veterinary medicine and a Ph.D. in Virology from the University of Bristol, England. |
| 2020-04-09 | Dr. Poste should continue to serve as a director of Exelixis due to his training as a scientist, his knowledge and experience with respect to the life sciences, healthcare and pharmaceutical industries, his broad leadership experience resulting from service on various boards, and his knowledge and experience with policymaking, regulatory issues and other governmental matters. |
| 2021-04-15 | Dr. Poste should continue to serve as a director of Exelixis due to his training as a scientist, his knowledge and experience with respect to the life sciences, healthcare and pharmaceutical industries, his broad leadership experience resulting from service on various boards, and his knowledge and experience with policymaking, regulatory issues and other governmental matters. |
| 2022-04-14 | Dr. Poste holds a DVM in veterinary medicine and a Ph.D. in Virology from the University of Bristol, England. |
| 2024-04-18 | Dr. Poste holds a DVM in veterinary medicine and a Ph.D. in Virology from the University of Bristol, England. |
Data sourced from SEC filings. Last updated: 2025-10-11